Bharat Immunologicals Revenue

BIBCL -- India Stock  

INR 11.26  0.37  3.18%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Bharat Immunologicals 
Revenue 
 = 
Money Received 
Discounts and Returns 
 = 
309.06M

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition
Based on latest financial disclosure Bharat Immunologicals Biologicals Corp Ltd reported 309.06M of revenue. This is 95.25% lower than that of the Healthcare sector, and 85.93% lower than that of Biotechnology industry, The Revenue for all stocks is 96.86% higher than the company.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Theme Ratings

Fundamental Indicators

Current Bharat Immunologicals financial ratios



 
Search macroaxis.com